Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study

被引：0
|
作者：
Naoto Iwai
Hiroaki Sakai
Kohei Oka
Junichi Sakagami
Takashi Okuda
Chie Hattori
Masashi Taniguchi
Tasuku Hara
Toshifumi Tsuji
Toshiyuki Komaki
Keizo Kagawa
Toshifumi Doi
Takeshi Ishikawa
Hiroaki Yasuda
Yoshito Itoh
机构：
[1] Fukuchiyama City Hospital,Department of Gastroenterology and Hepatology
[2] Kyoto Prefectural University of Medicine,Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Anamorelin; Lean body mass; Gastrointestinal cancer; Response; Clinical settings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy
    Fujii, Hironori
    Makiyama, Akitaka
    Nishimura, Kayoko
    Iihara, Hirotoshi
    Hirose, Chiemi
    Ohata, Koichi
    Yamada, Yunami
    Watanabe, Daichi
    Yasufuku, Itaru
    Okumura, Naoki
    Tanaka, Yoshihiro
    Takahashi, Takao
    Kobayashi, Ryo
    Matsuhashi, Nobuhisa
    Suzuki, Akio
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
  • [22] Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome
    Dev, Rony
    Amano, Koji
    Naito, Tateaki
    Del Fabbro, Egidio
    CURRENT ONCOLOGY REPORTS, 2024, 26 (07) : 762 - 772
  • [23] Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia
    Tsukiyama, Ikuto
    Iwata, Takashi
    Takeuchi, Tomoko
    Kato, Ryoko Inuzuka
    Sakuma, Masaki
    Tsukiyama, Sumiyo
    Kato, Mana
    Ikeda, Yoshiaki
    Ohashi, Wataru
    Kubo, Akihito
    Mori, Naoharu
    SUPPORTIVE CARE IN CANCER, 2023, 31 (12)
  • [24] Impact of the Combination of Anamorelin and Rehabilitation on Functional and Nutritional Outcomes in Patients with Cancer Cachexia
    Hasegawa, Makoto
    Sanmoto, Yohei
    Kono, Koji
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025, 77 (01): : 86 - 92
  • [25] Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia
    Ikuto Tsukiyama
    Takashi Iwata
    Tomoko Takeuchi
    Ryoko Inuzuka Kato
    Masaki Sakuma
    Sumiyo Tsukiyama
    Mana Kato
    Yoshiaki Ikeda
    Wataru Ohashi
    Akihito Kubo
    Naoharu Mori
    Supportive Care in Cancer, 2023, 31
  • [26] Endocrinological Changes after Anamorelin Administration in Patients with Gastrointestinal Cancer
    Kuraoka, Sakiko
    Iwamuro, Masaya
    Satomi, Takuya
    Yamazaki, Tatsuhiro
    Hamada, Kenta
    Kono, Yoshiyasu
    Kanzaki, Hiromitsu
    Kato, Hironari
    Otsuka, Fumio
    Okada, Hiroyuki
    ACTA MEDICA OKAYAMA, 2023, 77 (03) : 235 - 241
  • [27] Clinical practice of anamorelin therapy for cachexia in pancreatic cancer
    Okada, M.
    Ohba, A.
    Mitsunaga, S.
    Shibuki, T.
    Satake, T.
    Watanabe, K.
    Sasaki, M.
    Imaoka, H.
    Maruki, Y.
    Nagashio, Y.
    Susumu, H.
    Morizane, C.
    Ueno, H.
    Ikeda, M.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1600 - S1600
  • [28] Prescription Pattern of Anamorelin; a Therapeutic Agent for Cancer Cachexia
    Tambo, Yoshihiro
    Kajiura, Shinya
    Yoshida, Akihiro
    Chikaoka, Shingo
    Tanabe, Yuki
    Kanai, Nahoko
    Takayuki, Ando
    Ueda, Akira
    Moto, Iori
    Nakayama, Yurika
    Shima, Tomoko
    Matsushita, Yukiko
    Mizukami, Tatsuji
    Kainuma, Mosaburou
    Yasuda, Ichiro
    Hayashi, Ryuji
    JOURNAL OF PALLIATIVE MEDICINE, 2024, 27 (07) : 922 - 925
  • [29] A prospective study examining cachexia predictors in patients with incurable cancer
    Vagnildhaug, O. M.
    Brunelli, C.
    Hjermstad, M. J.
    Strasser, F.
    Baracos, V.
    Wilcock, A.
    Nabal, M.
    Kaasa, S.
    Laird, B.
    Solheim, T. S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] PALLIATIVE CARE Anamorelin provides benefit to patients with cachexia
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) : 68 - 68
12345